A key aspect of the project revolves around the development of the microfluidic chips. While the current generation of chips is made from glass plates, which are relatively expensive to produce, Saxion is working with Solstice Pharmaceuticals to create a more cost-effective, disposable plastic version. This shift is expected to drive down the overall cost of the device, making it a viable option for potential market introduction.
NANOSPRESSO is funded by the Dutch Research Agenda (NWA) ORC 2020/21 program. For more information about our partners, funding, and legal notices, please visit our contact page and follow us on social media.